Cell & Gene Therapy Clinical Trial Services Market Trends

Cell and Gene Therapy Clinical Trial Services Market Trends

The rapid pace of technological advancement in cell and gene therapy is a catalyst for the growth of the market. These advancements not only enhance the efficacy of treatments but also expand the therapeutic applications of cell and gene therapy across a wide range of diseases that is anticipated to boost the growth of the market.
 

• For instance, in April 2022, Labcorp a leading global life sciences company collaborated with Xcell Biosciences, Inc, a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market. Through this collaboration, LabCorp and Xcellbio work on a series of projects focused on improving the safety and efficacy of cell and gene therapies (CGTs). Thus, the demand for high-quality clinical trial services is expected to grow in tandem, ensuring the safe and effective translation of these innovative therapies from the laboratory to the hospitals & clinic, is anticipated to boost the growth of the market.